Contattaci Contact Us

20 September 2021 - Day 1

  • Welcome Addresses and Introduction

    Speaker Francesco Cosentino

    Session date 20/09/2021 - 08:30

  • Drivers of life expectancy

    Speaker Giovanni De Gaetano

    Session date 20/09/2021 - 08:40

  • Autoimmunity and oxidative stress

    Speaker Tomasz J. Guzik

    Session date 20/09/2021 - 09:00

  • Sirtuins, aging and CVD

    Speaker Thomas F. Luscher

    Session date 20/09/2021 - 09:20

  • Nitric oxide and redox changes in the myocardium

    Speaker Barbara Casadei

    Session date 20/09/2021 - 09:40

  • Discussion - Session I

    Speaker -

    Session date 20/09/2021 - 10:00

  • Lecture - What CT has taught us about prevention

    Speaker S. Achenbach

    Session date 20/09/2021 - 10:20

  • Regulatory mechanisms of platelet biology and blood coagulation

    Speaker Lina Badimon

    Session date 20/09/2021 - 11:20

  • Update on the mechanisms of acute coronary syndromes

    Speaker Filippo Crea

    Session date 20/09/2021 - 11:40

  • Is RNA interference to lower lipid atheroprotective?

    Speaker Ulf Landmesser

    Session date 20/09/2021 - 12:00

  • Regenerative cell exhaustion in cardiometabolic diseases

    Speaker S. Verma

    Session date 20/09/2021 - 12:20

  • Discussion - Session II

    Speaker -

    Session date 20/09/2021 - 12:40

  • Overweight/obesity in adolescents: a contemporary scourge

    Speaker J. Deanfield

    Session date 20/09/2021 - 14:00

  • Hypertension management and CV risk: lights and shadows

    Speaker Massimo Volpe

    Session date 20/09/2021 - 14:20

  • The role of dietary regimens in cardiometabolic health

    Speaker Ramon Estruch

    Session date 20/09/2021 - 14:40

  • How much exercise is enough?

    Speaker Martin Halle

    Session date 20/09/2021 - 15:00

  • Discussion - Session III

    Speaker -

    Session date 20/09/2021 - 15:20

  • SGLT2i and GLP1 RA: Moving treatment landscape forward

    Speaker Francesco Cosentino

    Session date 20/09/2021 - 16:10

  • Dyslipidemias: more powerful tools, more ambitious targets

    Speaker François Mach

    Session date 20/09/2021 - 16:30

  • Can real-word data inform clinical practice decision?

    Speaker Stefan James

    Session date 20/09/2021 - 16:50

  • Are we getting patients to target?

    Speaker Lars Ryden

    Session date 20/09/2021 - 17:10

  • Discussion - Session IV

    Speaker -

    Session date 20/09/2021 - 17:30

21 September 2021 - Day 2

  • Mechanistic insight into how aspirin prevents atherothrombosis

    Speaker Carlo Patrono

    Session date 21/09/2021 - 08:30

  • The rationale for combined platelet and anticoagulation inhibition

    Speaker Dominick J. Angiolillo

    Session date 21/09/2021 - 08:50

  • Tailoring antithrombotic therapy to revascularization procedures

    Speaker Stephan Windecker

    Session date 21/09/2021 - 09:30

  • Discussion - Session V

    Speaker -

    Session date 21/09/2021 - 09:50

  • Epicardial fat, inflammation and CV risk

    Speaker B. Cosyns

    Session date 21/09/2021 - 10:45

  • Cardiac imaging: coronary CT vs functional testing?

    Speaker Jeroen BAX

    Session date 21/09/2021 - 11:05

  • 2019 ESC guidelines and beyond

    Speaker Victoria Delgado

    Session date 21/09/2021 - 11:45

  • Discussion - Session VI

    Speaker -

    Session date 21/09/2021 - 12:05

  • 2021 ESC Guidelines on heart failure

    Speaker Giuseppe M.C. Rosano

    Session date 21/09/2021 - 13:30

  • The future of SGLT2 inhibition in cardiology

    Speaker Petar M. Seferovic

    Session date 21/09/2021 - 13:50

  • SwedeHF: real word treatment trends

    Speaker Lars H. Lund

    Session date 21/09/2021 - 14:10

  • Heart failure and atrial fibrillation: an evil conspiracy

    Speaker Christophe Leclercq

    Session date 21/09/2021 - 14:30

  • Atrial fibrillation: medical therapy or ablation?

    Speaker Frieder Braunschweig

    Session date 21/09/2021 - 14:50

  • Discussion - Session VII

    Speaker -

    Session date 21/09/2021 - 15:10

  • SGLT2 inhibitors: Diabetes or renal drugs?

    Speaker Per Henrik Groop

    Session date 21/09/2021 - 16:00

  • Principles for smooth CV drug therapy in the elderly

    Speaker Faiez Zannad

    Session date 21/09/2021 - 16:20

  • A claudicant patient with multisite artery disease

    Speaker Charalambos Vlachopoulos

    Session date 21/09/2021 - 16:50

  • Discussion - Session VIII

    Speaker -

    Session date 21/09/2021 - 17:10

Reserved area

APP FONDAZIONE MENARINI



Pills of Art Menarini

“Pills of Art”
A new multimedia project dedicated to the art world.



New Projects: MINUTI DIGITALE



Minuti Menarini Online

Subscribe for free to the paper version of the magazine



Fondazione Menarini



SIGN UP FOR THE NEWSLETTER

Receive information about the Fondazione Menarini every month.

TRACKEING_HIDDENFIELD_KEY

VGFM DATA-LAYER

Fondazione Menarini
Fondazione Menarini, Centro Direzionale Milanofiori 20089 Rozzano (MI) - Edificio L - Strada 6
Tel. +39 02 55308110 Fax +39 02 55305739 C.F. 94265730484